Allstate Corporation's ALL valuation remains favorable relative to returns, J.P. Morgan reports.
“We believe Allstate is significantly undervalued in absolute and relative terms,” J.P. Morgan writes. “Shares are trading at 0.96X book value excluding unrealized gains versus an average of 1.04X for non-life stocks. Given, we believe ALL can cover its cost of capital over the next three years, something most of non-life companies we cover are unlikely to do, we believe valuation has room to improve.”
Allstate Corporation closed Wednesday at $30.76.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in